Viewing Study NCT03356158


Ignite Creation Date: 2025-12-25 @ 12:01 AM
Ignite Modification Date: 2026-01-10 @ 2:12 PM
Study NCT ID: NCT03356158
Status: UNKNOWN
Last Update Posted: 2018-09-17
First Post: 2017-11-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Metastatic Colorectal Cancer
Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module